Monitor upcoming earnings and any regulatory developments on U.S. menthol ban or FDA actions — the divergence between large passive accumulators and quant/active sellers suggests the stock's risk/reward is debated. The net inflow is notable but 13F data is 45+ days stale; check for any subsequent insider buying or selling to confirm conviction.
Executive Summary
A mixed institutional cluster in BTI shows 37 buyers adding $375.1M in new positions, led by Morgan Stanley (+$172M), Citigroup (+$88.6M), and Cullen Capital (+$55.8M), while 21 sellers reduced by $131.2M, including full exits by Point72 and Jane Street and near-exits by RenTech and Optiver. The divergence between large passive accumulators and quant/active sellers suggests uncertainty around BTI's regulatory and litigation outlook, with the net $243.9M inflow reflecting institutional conviction in the dividend yield and global footprint despite headwinds.
Key Financial Metrics
Institutional Positions
Net institutional flow: $243.9M
▲ Buyers (37)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | ADD | +48.2% | $476.0M | $172.0M |
| Cullen Capital | ADD | +61.9% | $134.4M | $55.8M |
| Citigroup | DOUBLED | +1119.2% | $96.0M | $88.6M |
| D.E. Shaw | DOUBLED | +144.7% | $66.4M | $40.7M |
▼ Sellers (21)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Point72 | EXIT | -100% | $24.2M | -$24.2M |
| Jane Street Group | EXIT | -100% | $11.3M | -$11.3M |
| RenTech | NEAR_EXIT | -98.1% | $34.0M | -$33.3M |
| Bridgewater | TRIM | -33.8% | $44.8M | -$13.5M |
Key Facts
- 37 institutional buyers added $375.1M in new BTI positions during Q2 2026, while 21 sellers reduced by $131.2M
- Morgan Stanley added 2.51M shares (+48.2%), increasing its stake from $304M to $476M
- Citigroup more than doubled its position (+1,119%), adding $88.6M in value
- Point72 and Jane Street fully exited their BTI positions, liquidating $24.2M and $11.3M respectively
- Renaissance Technologies reduced by 98.1%, exiting all but a token position worth $679K
- Bridgewater trimmed 33.8% of its BTI stake, selling $13.5M
Financial Impact
Net institutional inflow of $243.9M during Q2 2026 ($375.1M bought vs $131.2M sold)
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound since quarter-end
- Full exits by Point72 and Jane Street signal skepticism from active quant managers
- Regulatory and litigation overhangs (U.S. menthol ban, FDA authorization) remain unresolved
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-BTI-2026-Q2 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 6-K | $59.48 | awaiting T+20 | — | — |
Oct 20, 2026 6d ago | 6-K | $59.11 | awaiting T+20 | — | — |
Oct 15, 2026 11d ago | 6-K | $58.00 | awaiting T+20 | — | — |
Oct 12, 2026 14d ago | Institutional Cluster | $55.62 | awaiting T+20 | — | — |
Oct 9, 2026 17d ago | 6-K | $55.50 | awaiting T+20 | — | — |
Oct 7, 2026 19d ago | 6-K | $53.90 | awaiting T+20 | — | — |
Oct 2, 2026 24d ago | 6-K | $52.64 | awaiting T+20 | — | — |
Oct 1, 2026 25d ago | 6-K | $52.36 | awaiting T+20 | — | — |
Sep 29, 2026 27d ago | 6-K | $53.99 | awaiting T+20 | — | — |
Sep 9, 2026 6w ago | 6-K | $54.33 $53.90 | ▼ −0.79% | ▼ −2.74% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers